4628 Federal Register / Vol. 87, No. 19 / Friday, January 28, 2022 / Notices 

TABLE 1—ESTIMATED ANNUAL RECORDKEEPING BURDEN 1

21 CFR part Number of 

recordkeepers 

Number of 

records per 

recordkeeper 

Total 

annual 

records 

Average 

burden per 

recordkeeping 

Total hours 

Written procedures; 589.2000(e)(1)(iv) ...................... 300 1 300 14 4,200 

1There are no capital costs or operating and maintenance costs associated with this collection of information. 

We base our estimate of the number 

of recordkeepers on inspectional data. 

Based on a review of the information 

collection since our last request for 

OMB approval we have adjusted our 

burden estimate, which has resulted in 

a decrease to the currently approved 

burden. Review of our inspection data 

suggests that the number of facilities 

that need to conduct these separation 

practices is gradually decreasing, 

therefore we have decreased the number 

of facilities who must comply, as well 

as the total number of hours needed to 

comply with this burden. 

Dated: January 24, 2022. 

Lauren K. Roth, 

Associate Commissioner for Policy. 

[FR Doc. 2022–01731 Filed 1–27–22; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket Nos. FDA–2011–N–0742; 

FDA–2018–N–0180; FDA–2019–N–2854; 

FDA–2021–N–0515; FDA–2014–N–1960; 

FDA–2017–D–6069; and FDA–2019–N–3325] 

Agency Information Collection 

Activities; Announcement of Office of 

Management and Budget Approvals 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is publishing a 

list of information collections that have 

been approved by the Office of 

Management and Budget (OMB) under 

the Paperwork Reduction Act of 1995. 

FOR FURTHER INFORMATION CONTACT: Ila 

S. Mizrachi, Office of Operations, Food 

and Drug Administration, Three White 

Flint North, 10A–12M, 11601 

Landsdown St., North Bethesda, MD 

20852, 301–796–7726, PRAStaff@

fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: The 

following is a list of FDA information 

collections recently approved by OMB 

under section 3507 of the Paperwork 

Reduction Act of 1995 (44 U.S.C. 3507). 

The OMB control number and 

expiration date of OMB approval for 

each information collection are shown 

in table 1. Copies of the supporting 

statements for the information 

collections are available on the internet 

at https://www.reginfo.gov/public/do/ 

PRAMain. An Agency may not conduct 

or sponsor, and a person is not required 

to respond to, a collection of 

information unless it displays a 

currently valid OMB control number. 

TABLE 1—LIST OF INFORMATION COLLECTIONS APPROVED BY OMB 

Title of collection OMB control 

No. 

Date approval 

expires 

Registration of Producers of Drugs and Listing of Drugs in Commercial Distribution ............................................ 0910–0045 12/31/2024 

Generic Clearance for the Collection of Qualitative Data on Tobacco Products and Communications ................ 0910–0810 12/31/2024 

Premarket Tobacco Product Applications and Recordkeeping Requirements ....................................................... 0910–0879 12/31/2024 

Postmarketing Adverse Experience Reporting and Recordkeeping ....................................................................... 0910–0230 1/31/2025 

MedWatch: Adverse Event and Product Experience Reporting System (Paper Based) ....................................... 0910–0291 1/31/2025 

De Novo Classification Process (Evaluation of Automatic Class III Designation) .................................................. 0910–0844 1/31/2025 

Laboratory Accreditation for Analyses of Foods ..................................................................................................... 0910–0898 1/31/2025 

Dated: January 20, 2022. 

Lauren K. Roth, 

Associate Commissioner for Policy. 

[FR Doc. 2022–01692 Filed 1–27–22; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Biodefense Science Board 

AGENCY: Office of the Assistant 

Secretary for Preparedness and 

Response (ASPR), Department of Health 

and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: The National Biodefense 

Science Board (NBSB or the Board) is 

authorized under Section 319M of the 

Public Health Service (PHS) Act, as 

added by Section 402 of the Pandemic 

and All-Hazards Preparedness Act of 

2006 and amended by Section 404 of the 

Pandemic and All-Hazards 

Preparedness Reauthorization Act. The 

Board is governed by the Federal 

Advisory Committee Act, which sets 

forth standards for the formation and 

use of advisory committees. The NBSB 

provides expert advice and guidance on 

scientific, technical, and other matters 

of special interest to the Department of 

Health and Human Services (HHS) 

regarding current and future chemical, 

biological, nuclear, and radiological 

agents, whether naturally occurring, 

accidental, or deliberate. Authority to 

manage and operate the NBSB, 

including to receive advice and 

recommendations from the Board, has 

been delegated by the Secretary of HHS 

to the Assistant Secretary for 

Preparedness and Response (ASPR). The 

NBSB will meet in public (virtually) on 

March 7, 2022, beginning at 12:30 p.m. 

Eastern time. ASPR invites stakeholders 

and the general public to attend and 

participate as appropriate. A detailed 

agenda and instructions to register to 

attend the meeting will be available on 

the NBSB meeting website https://

www.phe.gov/nbsb. 

Procedures for Public Participation: 

Members of the public may attend the 

meeting via a toll-free phone number or 

Zoom teleconference, which requires 

pre-registration. The meeting link to 

pre-register will be posted on the 

meeting website https://www.phe.gov/ 


jspears on DSK121TN23PROD with NOTICES1